News-Medical.Net Hidradenitis suppurativa News FeedLatest Hidradenitis suppurativa News and Researchhttps://www.news-medical.net/
en-GBNews-Medical.NetDermatology experts publish guidelines for diagnosing, managing hidradenitis suppurativaAn international team of dermatology experts including two from Henry Ford Hospital in Detroit have published – for the first time in North America - guidelines for diagnosing and managing hidradenitis suppurativa, a chronic and debilitating skin disease for which there is no cure.https://www.news-medical.net/news/20190806/Dermatology-experts-publish-guidelines-for-diagnosing-managing-hidradenitis-suppurativa.aspx
https://www.news-medical.net/news/20190806/Dermatology-experts-publish-guidelines-for-diagnosing-managing-hidradenitis-suppurativa.aspx#commenthttps://www.news-medical.net/post.aspx?id=96f27353-dcfe-4af3-93d1-85f6ccf4fd2fTue, 06 Aug 2019 22:41:39 -0400Dermcidin in human sweat may contribute to pathogenesis of hidradenitis suppurativaDermcidin, an anti-microbial peptide normally found in human sweat, may play a role in the pathogenesis of this chronic skin disease hidradenitis suppurativa, according to a research team from the George Washington University.https://www.news-medical.net/news/20190426/Dermcidin-in-human-sweat-may-contribute-to-pathogenesis-of-hidradenitis-suppurativa.aspx
https://www.news-medical.net/news/20190426/Dermcidin-in-human-sweat-may-contribute-to-pathogenesis-of-hidradenitis-suppurativa.aspx#commenthttps://www.news-medical.net/post.aspx?id=f85ce03a-84ca-40fe-b9a0-550cab1307faFri, 26 Apr 2019 01:11:00 -0400Survey: More than 52% of people living with debilitating skin condition wait over four years for a diagnosisTo mark HS (hidradenitis suppurativa) Awareness Week from 5-11 June 2017, the Champions for Change campaign calls for people who suspect they may have HS to go and see their GP without delay.https://www.news-medical.net/news/20170606/Survey-More-than-5225-of-people-living-with-debilitating-skin-condition-wait-over-four-years-for-a-diagnosis.aspx
https://www.news-medical.net/news/20170606/Survey-More-than-5225-of-people-living-with-debilitating-skin-condition-wait-over-four-years-for-a-diagnosis.aspx#commenthttps://www.news-medical.net/post.aspx?id=8e8bf7c5-6deb-40a3-bc4b-c8f48517cb4bTue, 06 Jun 2017 09:50:00 -0400AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HSAbbVie today announced results from a Phase 3 pivotal study demonstrating that HUMIRA® (adalimumab) is effective in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa (HS), specifically the number of abscesses and inflammatory nodules.https://www.news-medical.net/news/20140911/AbbViee28099s-Phase-3-pivotal-study-shows-HUMIRA-is-effective-in-reducing-symptoms-in-HS.aspx
https://www.news-medical.net/news/20140911/AbbViee28099s-Phase-3-pivotal-study-shows-HUMIRA-is-effective-in-reducing-symptoms-in-HS.aspx#commenthttps://www.news-medical.net/post.aspx?id=a81226d9-98dc-4822-9a6a-052432c1a020Thu, 11 Sep 2014 05:24:00 -0400AbbVie announces HUMIRA phase II study results for treating hidradenitis suppurativaAbbVie (NYSE: ABBV) today announced results from a post-hoc analysis of an investigational Phase II study, which evaluated HUMIRA® (adalimumab) in the treatment of patients with moderate-to-severe hidradenitis suppurativa (HS) after 16 weeks of therapy.https://www.news-medical.net/news/20131007/AbbVie-announces-HUMIRA-phase-II-study-results-for-treating-hidradenitis-suppurativa.aspx
https://www.news-medical.net/news/20131007/AbbVie-announces-HUMIRA-phase-II-study-results-for-treating-hidradenitis-suppurativa.aspx#commenthttps://www.news-medical.net/post.aspx?id=f441a680-e8d1-4ad4-9ac6-5439d233a7fbMon, 07 Oct 2013 00:34:00 -0400Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HSAbbott today announced the initiation of two Phase 3 clinical trials designed to evaluate the safety and efficacy of an investigational use of HUMIRA (adalimumab) in adult patients with moderate to severe hidradenitis suppurativa.https://www.news-medical.net/news/20120316/Abbott-initiates-enrollment-in-two-HUMIRA-Phase-3-trials-for-moderate-to-severe-HS.aspx
https://www.news-medical.net/news/20120316/Abbott-initiates-enrollment-in-two-HUMIRA-Phase-3-trials-for-moderate-to-severe-HS.aspx#commenthttps://www.news-medical.net/post.aspx?id=d1618d82-5276-4879-acae-81dbf12e7e1aFri, 16 Mar 2012 01:09:45 -0400MEDIHONEY dressings effective in treating chronic wounds in childrenChronic, non-healing wounds can be a serious problem for children as many currently available treatment modalities can be too harsh or toxic. At the 2010 Symposium on Advanced Wound Care (SAWC) and the Wound Healing Society (WHS), an international conference drawing clinicians from all over the globe which was held April 17-20 in Orlando, two clinicians presented case series illustrating the benefits of MEDIHONEY® dressings for this challenging patient population.https://www.news-medical.net/news/20100417/MEDIHONEY-dressings-effective-in-treating-chronic-wounds-in-children.aspx
https://www.news-medical.net/news/20100417/MEDIHONEY-dressings-effective-in-treating-chronic-wounds-in-children.aspx#commenthttps://www.news-medical.net/post.aspx?id=7279e6a8-b79f-4066-b1c0-b0c5f8dc5bc4Sat, 17 Apr 2010 07:19:47 -0400Zinc salts can provide an effective treatment for Verneuil's diseaseVerneuil's disease is a chronic, suppurative dermatosis involving the apocrine glands with a severe impact on the quality of life.https://www.news-medical.net/news/2007/04/30/24404.aspx
https://www.news-medical.net/news/2007/04/30/24404.aspx#commenthttps://www.news-medical.net/post.aspx?id=8f7b484d-bd06-46e8-bca6-47b1cf6e045eMon, 30 Apr 2007 23:02:00 -0400